Noile-Immune Biotech Inc. (TYO:4893)
Japan · Delayed Price · Currency is JPY 140.00
+1.00 (0.72%)
Aug 6, 2026, 1:23 PM JST
Noile-Immune Biotech Market Cap
Noile-Immune Biotech has a market cap or net worth of 6.03 billion as of August 5, 2026. Its market cap has decreased by -19.00% in one year.
Market Cap
6.03B
Enterprise Value
2.29B
Revenue
3.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
140.00
ChartMarket Cap Chart
Since June 28, 2023, Noile-Immune Biotech's market cap has decreased from 30.89B to 6.03B, a decrease of -80.47%. That is a compound annual growth rate of -40.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2026 | 6.03B | 4.75% |
| Dec 30, 2025 | 5.76B | -21.76% |
| Dec 30, 2024 | 7.36B | -19.77% |
| Dec 29, 2023 | 9.17B | -70.30% |
| Jun 28, 2023 | 30.89B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kidswell Bio | 7.25B |
| ADR Biomedical Holdings | 7.06B |
| MEDINET | 7.04B |
| BrightPath Biotherapeutics | 6.67B |
| CellSource | 6.39B |
| Carna Biosciences | 6.25B |
| Chordia Therapeutics | 6.03B |
| PRISM BioLab Co.,LTD | 5.80B |